A Case of Successful Treatment of Small Cell Carcinoma of the Bladder with Pembrolizumab

Small cell carcinoma of the bladder (SCCB) is a rare cancer that accounts for approximately 1% of primary malignant bladder tumors. It is highly malignant and has a poor prognosis. Similar to small cell lung cancer, platinum-based chemotherapy is recommended as the first-line therapy, and amrubicin...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 70(2024), 4 vom: 12. Apr., Seite 93-99
1. Verfasser: Aigase, Tomohiko (VerfasserIn)
Weitere Verfasser: Tatenuma, Tomoyuki, Uemura, Koichi, Makiyama, Kazuhide, Kobayashi, Noritoshi, Kato, Ikuma, Yamanaka, Shoji, Fujii, Seiji
Format: Online-Aufsatz
Sprache:Japanese
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Case Reports Journal Article English Abstract pembrolizumab DPT0O3T46P Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological